Bridging the childhood epilepsy treatment gap in northern Nigeria (BRIDGE): Rationale and design of pre-clinical trial studies

Epilepsy is the most common serious childhood neurological disorder. In the low- and middle-income countries (LMICs) of Africa, children with epilepsy suffer increased morbidity and mortality compared to their counterparts in high-income countries, and the majority do not receive treatment – the childhood epilepsy treatment gap. Reports of the childhood epilepsy treatment gap in Africa are likely underestimates; most surveys do not include several common childhood seizure types, including most types of non-convulsive epilepsy. Efforts to scale up childhood epilepsy care services in the LMICs of Africa must contend with a shortage of physicians and diagnostic technology [e.g., electroencephalograms (EEGs)]. One pragmatic solution is to integrate epilepsy care into primary care by task-shifting to community health extension workers. The aims of this project (BRIDGE) are to: 1) train, develop, and pilot task-shifted epilepsy care teams; 2) develop and pilot innovative childhood epilepsy screening and diagnostic paradigms adapted to the local Hausa language/culture in Kano, northern Nigeria; and, 3) quantify and map the childhood epilepsy treatment gap, using geographic information systems (GIS), to target limited resources to areas of greatest need. Task-shifted teams will diagnose and manage childhood epilepsy using an innovative epilepsy screening tools and diagnostic and management paradigms in environments with limited EEG access. If validated and demonstrated efficacious in clinical trials, this project can be taken to scale across broader areas of west Africa’s LMICs that share language and culture. BRIDGE has the potential to enhance access to basic childhood epilepsy care and establish the foundation for childhood epilepsy clinical trials in west Africa. Since 2008, Vanderbilt University Medical Center (VUMC), Aminu Kano Teaching Hospital (AKTH), and key partners in northern Nigeria have supported clinical care and research targeting the needs of people in northern Nigeria with HIV, sickle cell disease (e.g., stroke prevention), renal disease and epilepsy with funding from the U.S. National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention/U.S. President’s Emergency Plan for AIDS Relief (CDC/PEPFAR), and other organizations [36,[45], [46], [47], [48], [49], [50], [51], [52]]. Kano is the state capital of Kano State in Nigeria and the second largest metropolis in Nigeria. Kano metropolis is comprised of eight local government areas (LGAs) —Dala, Fagge, Gwale, Kano Municipal, Kumbotso, Nasarawa, Tarauni, and Ungogo. The total area of metropolitan Kano urban area is 251 square kilometers, with an estimated population of 3,680,000. Kano state has an estimated population of 13,076,892. Although Nigeria has made economic progress over the past few decades, about half of people in northern Nigeria live in extreme poverty. Almost half of people in Kano are under the age of 18 years. These studies will be conducted in eight primary healthcare centers (PHCs) randomly selected from a pool of 167 PHCs in metropolitan Kano that offer primary maternal and child health care services. Kano is the largest population center of the Hausa people, who are heavily concentrated in northern Nigeria and southern Niger, with significant Hausa populations in Chad, Ghana, Cameroon, Togo, and Sudan. Spoken by up to 120 million people, Hausa is the third most commonly spoken language in Africa, behind only Arabic and Swahili, and is the most commonly spoken language in west Africa [53,54]. Hausa-translated educational materials and instruments demonstrated as effective in this study can be used across other Hausa-speaking populations. Other minority ethnic groups in Kano include the Fulani (most speak Hausa), Yoruba, Igbo and Kanuri. BRIDGE seeks to close the epilepsy treatment gap by developing and testing sustainable models of childhood epilepsy care that have the potential to be taken to scale in northern Nigeria, and throughout the LMICs of Africa, with an initial focus on childhood epilepsy among the Hausa people. Novel systems of epilepsy care (e.g., task-shifting epilepsy care to specially-trained community health extension workers [CHEWs]) and innovative diagnostic paradigms that most efficiently and effectively utilize scarce diagnostic resources (e.g. EEGs) have not been well-established or tested in clinical trials in African LMICs. BRIDGE will emphasize work performed at a network of primary healthcare centers (PHCs) in Kano, and a major tertiary care referral center (Aminu Kano Teaching Hospital, AKTH), to enhance access to epilepsy care and establish the foundation for childhood epilepsy clinical trials. BRIDGE will build upon the clinical and research platforms in Kano to enhance clinical capacity and increase access to epilepsy care, and establish the foundation for childhood epilepsy clinical trials through the following Specific aims: In addition, three qualitative evaluations will be conducted to: 1) assess patients’ family satisfaction with health services delivered by epilepsy care teams and CHEWs; 2) evaluate health care worker satisfaction with the new epilepsy care team and task-shifted care approach; and 3) perform an audit of diagnostic EEG services in Kano, including physicians and technologists with EEG expertise, and available EEG machines. An overview of the BRIDGE timeline is shown in Fig. 1. BRIDGE timeline. The three specific aims of this study are tightly integrated and coordinated during the two-year timeline (Fig. 1). Following approval by the internal review boards (IRB), and approval by the Kano State Ministry of Health, eight participating PHCs will be randomly selected – one from each of the eight local government areas of metropolitan Kano. One of the local government areas (Kumbotso) is primarily a rural area, with a small urban component. An epilepsy education program, developed for community health workers, will be administered to a cohort of CHEWs. From this cohort, CHEWs who successfully complete the training program will be selected to conduct community cross-sectional surveys to quantify and map the epilepsy treatment gap in Kano, and participate as members of epilepsy care teams working at the participating PHCs. Parallel to the epilepsy education program the epilepsy diagnostic screening instruments and paradigms were developed. The childhood epilepsy screening instrument, modified for use in Kano by adding questions to enhance seizure type classification and by translating to Hausa, will undergo validation in two populations – pediatric clinic populations in Kano, and door-to-door surveys in neighborhoods served by the participating PHCs. In addition, qualitative evaluations will be performed to assess satisfaction of patients, family members, and healthcare workers. An audit of the diagnostic EEG services available in Kano will be performed (Fig. 1). Ethical approval for this study was obtained from the Aminu Kano Teaching Hospital (AKTH) Research Ethics Committee, and the Institutional Review Board at Vanderbilt University Medical Center. The Kano State Ministry of Health also approved the study. Following approvals from the IRBs and the Kano State Ministry of Health, a computer-based random number generator will be used to randomly select eight PHCs from a pool of a total of 167 PHCs in the eight local governmental areas of metropolitan Kano. The site chosen in one of the eight local governmental areas, Kumbotso, will be located in a rural area. The managers of each of the randomly selected eight PHCs will give permission for their PHC to participate in the BRIDGE project. If any of the eight randomly selected PHCs declines to participate, the reason(s) will be documented, and another PHC from the same local government area will be randomly selected for participation. By randomly selecting PHCs from each of the governmental areas of metropolitan Kano, we will seek to achieve a representative sample of PHCs, avoid a clustering of the study sites within a single region of the city, and reduce the likelihood of movement of patients between the participating PHCs. One CHEW currently working in each of the eight randomly selected PHCs will be selected for training in childhood epilepsy. Following successful completion of training, these eight CHEWs will work half-time on the project. An additional 15 CHEWs who are recent graduates of the CHEW training program at the Kano State School of Health Technology or similar schools who show an interest in the project and the training will also be enrolled in the epilepsy training program. From these additional CHEWs, 10 who academically excel in the training program will also be hired to work on the project, each assigned to one of the eight participating PHCs. In addition, we will train 2 additional Community Health Officers (CHOs) in the epilepsy training program, each of whom will be hired at 50% effort to work on the project and supervise the CHEWs. The training program was modified from nurse training programs in pediatric epilepsy designed for new-onset seizure clinics in the U.S., adapted to the needs of Kano. This program was then refined by investigators at Vanderbilt University Medical Center and Aminu Kano Teaching Hospital (AKTH) using a flipped classroom pedagogical model, including a series of 33 brief recorded lectures (10–18 min each), with each lecture paired with a case-based group activity that reinforces the new material taught in the lecture. Each CHEW in the training program will be provided an android tablet, loaded with the recorded lectures, case-based group activities, and other learning materials to facilitate review and study. The greater than 60-hour epilepsy training program will be free of charge. The initial period of training will include one to two weeks of full-time lectures and group activities, followed by weekly to bi-weekly follow-up lectures and meetings with other CHEWs and community health officers (CHOs). After the initial week of intensive epilepsy training, CHEWs will see patients under the supervision of physicians with expertise in epilepsy, as well as have follow-up lectures and group activities. CHEWs and CHOs will take daily quizzes during the initial week of training, and then a comprehensive quiz after the first two months of the epilepsy education program. Focus groups will be conducted, before and after completion of the epilepsy course as part of the evaluation of the epilepsy education program. All CHEWs who complete the epilepsy education program will receive a certificate from Vanderbilt Institute for Global Health and Aminu Kano Teaching Hospital. The material covered during the intensive epilepsy education program will include: 1) clinical neuroanatomy and neurophysiology, with an emphasis on the cerebral cortex; 2) the basics of childhood stroke (common among children with sickle cell anemia in Kano); 3) basics of the neurological examination; 4) seizure definition, classification, and semiology (with video examples of seizures); 5) multiple lectures on major childhood epilepsy syndromes; 6) common co-morbid conditions associated with childhood epilepsy; 7) febrile seizures; 8) status epilepticus; 9) single seizures and post-traumatic seizures; 10) symptomatic seizures associated with infections (e.g., meningitis, malaria); 11) non-epileptic events; and, 12) an introduction to epilepsy treatment, with a review of the major anti-epileptic drugs (AEDs) available for use in Kano – phenobarbital, carbamazepine, and valproate. Other important topics covered include stigma, challenges of sustaining AED therapy, and seizure precautions and safety measures (e.g., keeping child aware from fires). Lectures will also be provided on newer AEDs that are rarely available (e.g., levetiracetam), and older medications still in use in northern Nigeria (e.g., paraldehyde, used for status epilepticus). The pharmacy technicians working at the participating PHCs will receive basic additional education in epilepsy and the typically available AEDs. In addition, primary care physicians working in Kano who receive referrals from the participating PHCs will also be provided access to the epilepsy education program materials and consultations with the physician epilepsy specialists on the BRIDGE project. Following the initial month of training, the CHEWs and CHOs will continue to evaluate patients under the supervision of physicians with expertise in epilepsy for approximately five months. Supplemental education sessions will continue on a regular basis, and supplemental epilepsy education sessions will be scheduled for the group. The CHEWs will learn and practice the details of the new childhood epilepsy screening instruments and diagnostic paradigms as they are developed by the study team and will begin functioning in teams of 2–4 CHEWs, with CHEWs supervised by a CHO and by physicians with expertise in epilepsy. The CHEWs and CHOs who complete the epilepsy training program will undergo a comprehensive evaluation/examination that will include a written examination as well as an evaluation by one or more of the physician epilepsy specialists regarding clinical evaluation of epilepsy patients. The childhood epilepsy diagnostic guidelines from WHO for use in low-resource settings of Africa will inform our task-shifted care protocol, with a focus on addressing the needs of children with epilepsy who are not sufficiently addressed by the WHO guidelines [41] – those with absence epilepsy, myoclonic seizures, atonic seizures, and less common epilepsy syndromes (e.g., epileptic spasms), including those with epilepsy who do not achieve seizure freedom after the first AED is administered in appropriate doses. These diagnostic guidelines will reflect the reality of limited access to EEGs for children in Kano. The diagnostic and treatment guidelines and systems utilized in the Paediatric Epilepsy Training (PET) courses and modules (developed by the British Pediatric Neurology Association, https://www.bpna.org.uk/pet/), previously piloted throughout Africa, will also inform this further development of the childhood epilepsy paradigms. A recently validated epilepsy screening, diagnosis and seizure type classification tool [55] has been modified and expanded with the intent of improving ascertainment of specific non-convulsive seizures thought to possibly be under-ascertained with the initial instrument. The modified epilepsy screening, diagnosis and seizure type classification tool will be validated in both clinics and in community screening (e.g., door-to-door surveys) after translation to Hausa, and will be a useful tool for gathering preliminary information on patients with suspected epilepsy, and assist the CHEW in obtaining additional information to clarify the history of possible seizures (Fig. 2). The proposed childhood epilepsy diagnostic and management guidelines will be reviewed by an advisory panel of experts in pediatric neurology. Childhood Epilepsy Screening & Seizure Classification Tool∗. ∗Modified and expanded from Patel AA et al. Epilepsy & Behavior 2016; 59:57–61, with permission. #Question 2 added to screen for absence seizures & focal non-motor seizures %Questions 11 and 12 were separated into two questions. A community epilepsy education and awareness campaign will begin with meetings with key community leaders and stakeholders in areas served by the participating PHCs, followed by educational programs at local schools and/or local community centers, and radio programs in Hausa language. The radio broadcasts will feature AKTH physicians with special expertise in epilepsy and child neurologists who will present basic information about epilepsy, the BRIDGE studies and the community surveys, and answer questions from the audience. As per prior agreement, these public service radio broadcasts will be recorded, and the radio shows will be re-played weekly for four weeks, and then be made available for ongoing community information sessions. The primary educational messages will be: 1) seizures and epilepsy are disorders of the brain that can be effectively treated; 2) a general description of types of seizures; 3) some, perhaps many, children with seizures who can be treated effectively with medication are not receiving treatment; and 4) AKTH is conducting research to develop new ways to deliver medical care to more children with epilepsy. Focus group discussions (FGDs) and key informant interviews (KIIs) will be conducted with community leaders and community representatives. A validated Hausa version of an epilepsy screening and seizure type classification tool is key to both the pilot of task-shifted childhood epilepsy care (Aim 2) and mapping the childhood epilepsy treatment gap in Kano (Aim 3). An epilepsy screening tool initially validated among children in Zambia and Tanzania [55] was modified to increase the predictive values for types of focal-onset seizures (e.g., frontal and temporal lobe), generalized seizures (e.g., absence, atonic, myoclonic), and specific epilepsy syndromes (e.g., juvenile myoclonic epilepsy [56], nodding syndrome [57], Lennox-Gastaut syndrome [17,58,59], and infantile spasms [60,61]). The epilepsy screening tool consists of three initial screening questions, with a “yes” answer to any screening question prompting an additional 15 questions to refine descriptions for seizure type classification and recognition of childhood epilepsy syndromes (Fig. 2). With active collaborations between Hausa-speaking epilepsy specialists at AKTH and linguists at the Bayero University Center for Nigerian Languages and Folklore, the tool was translated to Hausa, back-translated to English and piloted by physician epilepsy specialists in Hausa. Epilepsy-trained CHEWs participated in the final editing of the Hausa translation of the tool and trained in its administration. Both Hausa and English versions of the epilepsy screening and seizure type classification tool will be put into REDCap®, a secure web application developed by Vanderbilt University for managing surveys and databases [62], and loaded onto android tablet computers used by the epilepsy-trained CHEWs and physicians. The childhood epilepsy screening questionnaire (Fig. 2) will be validated in two separate populations – (1) a pediatric clinic-based population at Murtala Muhammad Hospital (Kano) and at AKTH, and (2) a community-based population of children ascertained using the questionnaire. We will not exclude non-Hausa speakers from the study. Such participants will be administered the English version of the epilepsy screening and seizure type classification tool. Children (≥6 months, < 18 years) who screen positive in the survey, or in the pediatric clinics, will obtain an evaluation, including a history and physical examination, by a CHEW and by one of the physician epilepsy specialists at AKTH at no charge to the family. The diagnosis (epilepsy versus not epilepsy) and seizure type classification by a physician epilepsy specialist in Kano who speaks the local languages and knows the local culture will be used as the gold standard in the validation studies. A senior pediatric neurologist and epilepsy expert based at the Vanderbilt data coordinating center (ET) will review the screening tool data from all positive screens and the random sample of negative screens; blinded to the results of the physician and CHEW exams, and use a previously developed paradigm to determine “tool epilepsy diagnosis and classification of seizure types (generalized or focal onset)” based on the tool data alone. The sensitivity and specificity of the tool for epilepsy diagnosis, and the predictive values for epilepsy diagnosis will be determined. Among those children who screen positive for epilepsy, the predictive value of a positive screen for generalized seizures and for focal-onset seizures, as well as the predictive value of a negative screen for generalized seizures and for focal-onset seizures, will be determined. Parental consent and childhood assent will be obtained prior to the examinations. If the patient identified with epilepsy is not receiving treatment, and if medical treatment is deemed necessary after the CHEW and physician exams, subsequent treatment will be provided by a CHEW in the pilot of task-shifted childhood epilepsy care, after informed consent. Parents/guardians of children with untreated epilepsy who do not consent for task-shifted epilepsy care (Fig. 3), will be referred to available local healthcare resources for epilepsy care, including community physicians. We will not exclude non-Hausa speakers from the study. Such participants will be administered the English version of the epilepsy screening and seizure type classification tool. BRIDGE Task-shifted Childhood epilepsy Protocol. Screening for childhood epilepsy, diagnostic evaluations of children who screen positive, and classification of childhood seizure types by clinical criteria will be piloted by epilepsy-trained CHEWs under the supervision of BRIDGE Kano-based physicians with expertise in epilepsy, and with adherence to the task-shifted protocol monitored by Kano-based investigators, and via the case report forms (CRFs) uploaded to the Vanderbilt data coordinating center. Parents of children (ages ≥ 6 months, < 18 years) who screen positive for epilepsy during the door-to-door surveys or the clinic surveys and are found to have epilepsy after their initial evaluation by a CHEW and a physician epilepsy specialist will be given the option for their child to receive epilepsy care by an epilepsy-trained CHEW at a local randomly selected PHC. After informed consent, the patient will be followed for epilepsy care by an epilepsy-trained CHEW, who will in turn be supervised by a CHO with specialized training in epilepsy and a physician epilepsy specialist – together, these form the epilepsy care team. Parents who do not wish for their child to receive task-shifted care via CHEWs at their local PHCs will be able to seek epilepsy care via the usual standard of care in Kano. The overview of the task-shifted childhood epilepsy care protocol is outlined in Fig. 3. Children who are clinically diagnosed with epilepsy by a study physician and receive care from an epilepsy care team will receive standard of care AEDs available in northern Nigeria. Ours is not a study of a new drug(s), and only available and long-approved AEDs typically used in epilepsy care will be utilized. Nevertheless, for families who are unable to pay for their child's medication, efforts will be made to subsidize the costs of AEDs using private donor funds, based upon the financial needs of the child's family. Children diagnosed as having focal-onset seizures will be prescribed carbamazepine or phenobarbital. Children with absence seizures and/or myoclonic seizures, with or without generalized tonic-clonic seizures, will be prescribed valproate. Phenobarbital may be used in selected situations for patients with myoclonic seizures. If ethosuximide is available for absence seizures, this may also be prescribed. Children with generalized tonic-clonic seizures, without absence seizures or myoclonic seizures, will be prescribed phenobarbital or valproate. Children with focal epilepsy with secondary generalized tonic-clonic seizures may also be treated with carbamazepine. Levetiracetam, typically not available and expensive, may also be used for children with seizures associated with focal-onset epilepsy or primary generalized epilepsy, if available and affordable. Typical contraindications for specific anti-epileptic drugs used in clinical practice (e.g., previous allergy to the drug) will be followed (Fig. 3) [[63], [64], [65]]. All females of childbearing age enrolled in task-shifted care will be referred by CHEWs to a family planning clinic (CHEW-operated, and typically in the PHC) as per routine practice, where oral contraceptives are available, and all patients will be prescribed multivitamins with folic acid. Any patient who becomes pregnant while enrolled in task-shifted epilepsy care will be referred to a physician for consultation [66]. Standard of care for managing epilepsy during pregnancy will be followed, consistent with medications and treatments available in northern Nigeria. Medication dosing guidelines will be according to standard of care and will be followed by the CHEW as outlined in the epilepsy training, and by the physician epilepsy specialist who prescribes the medication during the initial diagnostic visit [63]. Children who continue to have seizures, despite appropriate doses of the first AED, will be referred by the CHEW to the physician epilepsy specialist for further evaluation (Fig. 3). Due to limited EEG availability, EEGs will only be performed on children for whom the diagnosis of epilepsy is not clear at the initial evaluation and/or children who continue to have seizures while on anti-epileptic medication(s), and will be ordered by the physician epilepsy specialist upon referral by the CHEW (Fig. 3). Following the initial diagnostic evaluation by the physician epilepsy specialist, routine clinic visits with epilepsy-trained CHEWs will occur at months 1 and 2, every three months, and as needed. At each clinic visit, seizure frequency and the presence or absence of AED adverse events and any other potential adverse events will be noted in the RedCap CRFs for each child, with CRFs uploaded to the Vanderbilt coordinating center, with review by both the Vanderbilt-based data coordinating center and the physician epilepsy specialists/investigators at AKTH in Kano, Nigeria. Outcome measures from this feasibility study will include; (a) feasibility of randomization of PHCs in Kano, (b) feasibility of recruitment from clinic settings and community (e.g., door-to-door surveys), (c) estimating resources (including personnel) needed for a cluster randomized clinical trial of task-shifted care, (d) piloting the data collection for primary and secondary outcome measures, and (e) determining the acceptability of the task-shifted intervention. The PIs will meet at least twice per year in Kano, and weekly via web-based conferencing, to evaluate the effectiveness of the epilepsy diagnostic guidelines and the functioning of the task-shifted epilepsy teams. The PIs will also evaluate the impact that the task-shifted care teams using the epilepsy diagnostic paradigms have on EEG laboratory referrals. The BRIDGE team will also conduct a detailed audit of the EEG laboratory capacity, including the number of physicians able to read pediatric EEGs, the number of healthcare professionals able to operate EEG machines in Kano, and the number and functioning of EEG machines in Kano. A report regarding the EEG capacity in Kano relative to the current demand for EEG diagnostic services will be developed by the BRIDGE Epilepsy investigators, reviewed by the BRIDGE Advisory Panel, and a final report will be submitted to the Kano State Ministry of Health and the senior management at AKTH. Specific Aim 3 will have three components (Fig. 1): 1) community epilepsy awareness and community education, during which time information about epilepsy and the upcoming survey will be provided to communities who will participate in the survey; 2) validation of epilepsy screening and seizure-type classification tool; and 3) the door-to-door childhood epilepsy survey with collection of GIS data to map the childhood epilepsy treatment gap. The door-to-door survey to ascertain children (≥6 months, < 18 years) with epilepsy will utilize the childhood epilepsy screening and seizure type classification tool translated to Hausa by the Bayero University Center for Nigerian Languages, Translation, and Folklore, and administered by epilepsy-trained CHEWs. This tool has been validated in Zambia and Tanzania [55], and modified by the BRIDGE investigators to better ascertain focal-onset seizures, myoclonic seizures, infantile spasms, and nodding seizures for use in Kano (Fig. 2). As emphasized by linguists at the Center for Nigerian Languages, Translation, and Folklore the Hausa word typically used for the English term “epilepsy” literally refers only to convulsions that are associated with falls. Therefore, given the known under-ascertainment of non-convulsive epilepsy in prior door-to-door surveys and other epidemiology studies, and to avoid confusion among the Hausa people participating in the surveys, we are using the term “seizures” and referring to “seizures that benefit from treatment” (2 or more unprovoked afebrile seizures) instead of using the typical Hausa term for “epilepsy” in consent and assent documents. Additional questions designed to ascertain generalized absence seizures, atonic seizures, and myoclonic seizures, and infantile spasms have been added to the tool. The questionnaire will be uploaded into REDCap, and additional demographic data will be collected. The door-to-door questionnaire will be administered by epilepsy-trained CHEWs with additional training in administering questionnaires, and using REDCap for survey tools and CRFs. These CHEWs will be supervised by two CHOs, who will also receive additional training in epilepsy and questionnaire administration, and study physicians with training in epilepsy. After informed consent, the questionnaire will be administered by the CHEW via an interview with the parent at the home (likely the mother). Data collection will be performed using tablet computers. GPS coordinates of the residences of the participants will be recorded using the built-in GPS on the tablet computers used by the CHEWs to administer the epilepsy diagnostic questionnaire, and when needed, with separate hand-held GPS devices. An estimated 2,418 households will be surveyed in communities served by the eight participating PHCs in the metropolitan Kano area. To select the households, the survey team will use the ‘random walk’ method previously validated in WHO community surveys and utilized in other surveys in Kano [[67], [68], [69], [70]]. The steps used in selecting households for the survey is outlined in Fig. 4. In each sampled house, a structured questionnaire will be administered to the parent/guardian (typically mother) of children in the eligible age group after obtaining parental informed consent and assent for older children. All eligible respondents found in a household who are parents/guardians of children will be interviewed. After completing interviews in the first house, the next house whose door is nearest to the one just completed will be approached for the survey (Fig. 4). This process will be completed until the houses in the referral regions of each PHC have been surveyed, and/or when the total number of households surveyed exceeds 2,418 and an adequate number of households have been surveyed to adequately validate and pilot the survey questionnaire. Selecting Houses within communities for the childhood epilepsy door-to-door survey. The epilepsy-trained community health extension workers (CHEWs) conducting the community survey in Kano, Nigeria, often without standardized street signs or addresses, will take the following steps, as documented in this map derived from satellite images of Kano (a) Start at a central location (e.g., a mosque as in Fig. 4a). determined by the survey team with local health workers. (b) Spin a pen or pencil in the air and let it to fall on the ground. Investigators will begin walking in the direction indicated by the point of the pen/pencil. (c) The number of houses between the starting point and the boundary of the community will be counted (In Fig. 4a example, there are 11 houses.). (d) A random number (between 1 and 11) will be selected. To select the random number, the numbers will be written on pieces of paper, the pieces of papers will be mixed together, then one will be pulled out of the pile. (In the example, the number 11 was randomly selected.) (3) The random walk will begin at the house that matched the random number (house no. 11 in Fig. 4b). After completing the study in the first selected house, the interviewer will walk to the next closest house. Whenever it seemed that two houses are the same distance away, a coin will be flipped to decide between the two. Utilizing the Hausa version of the epilepsy screening and seizure type classification tool administered by epilepsy-trained CHEWs, children (≥6 months, < 18 years) who screen positive will undergo exams by CHEWs and physicians. Children who receive a physician's diagnosis of epilepsy and are determined to require treatment serve as the denominator; children who require medical treatment and who are not receiving treatment comprise the numerator for the calculation of the childhood epilepsy treatment gap. Study data will be collected and managed using REDCap, hosted at Vanderbilt University Medical Center [62]. REDCap is a secure, web-based application designed to support data capture for research studies, providing 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources. Study subject-level information will be collected as part this study. For all study subject-level data, only the program coordinator in Kano and the clinicians in Kano at each clinic site will have access to identifiable patient information that is also required for routine patient care. AKTH will store research data, including medical records and questionnaires, in locked cabinets, and all e-files will be password protected. This security of the data includes the mapping of the location of the children who are not receiving epilepsy care. These data will not have personal identifiers and will be separate from the data on children found to have epilepsy, and it should not be possible to identify an individual child by simply seeing a dot on a map from the region of Kano where the child resides. Raw coordinate data will be used only by necessary members of the study team, and published data mapping will be at the “ward” level. No data will be released with any information that may directly or indirectly identify participants, their survey responses, or laboratory results to outside agencies. CHEWs will use portable tablet computers to collect data in the field; these computers will be data-encrypted and password-protected. Additional measures to enhance security for data housed at Vanderbilt Institute for Global Health (VIGH) will be utilized. Access to all data will be ID and password-protected, including data warehouse software and computers managing and analyzing survey data. Enhanced security measures exist for VIGH, including 24-hour building security guards, after-hours elevator and stair lockouts, and key pad locks on all doors leading into offices. CRF data will contain personal identifying information for the duration of the BRIDGE project. After completion of the project, the electronic CRFs with personal identifying information will be transmitted to the patient's primary care patient record. The electronic data with only unique study numbers (and not names or other personal identifying information) will be used for identifying study subject records for data analysis at the completion of the BRIDGE project. A power analysis was performed to determine the urban and rural sample sizes needed to detect the difference between the urban childhood epilepsy treatment gap and the rural childhood epilepsy treatment gap in Kano. Two-sided tests were performed using the formula below, where n1 was rural sample size, n2 was urban sample size, α was the Type I error (significant level at 0.05), β was Type II error of 0.20 (power = 1–0.20 = 0.80), z1-α/2 was the critical value of the standard normal distribution at 1- α/2, z1- β was the critical value of the standard normal distribution at 1- β, p1 was the rural childhood epilepsy treatment gap, p2 was the urban childhood epilepsy treatment gap, and k was the ratio of n2 to n1. We calculated a range of sample sizes needed using a range of prevalence of active childhood epilepsy of 5–7 per 1000 in urban areas, a range of prevalence of active childhood epilepsy of 7–15 per 1000 in rural areas of Kano, and a range of epilepsy treatment gaps of 45%–65% in urban areas and of 75%–90% in rural areas, based upon prior published prevalence and treatment gap estimates in sub-Saharan Africa [[19], [20], [21], [22],[41], [42], [43], [44],[71], [72], [73], [74], [75], [76], [77]]. We estimated an average of 5.5 children per household in Kano. Based upon these assumptions, we estimated a likely necessary sample of households for the survey at 1768, with the maximum estimated 2418 households required in the sample. Our 18 epilepsy-trained CHEWs, who will also be trained in the use of the door-to-door questionnaire, will administer the questionnaire to mothers at approximately 1768 households to 2418 households over a period of 12–18 months, or fewer than 15 households per CHEW per month, which is about three households per CHEW per week, assuming 48 working weeks per year. The childhood epilepsy treatment gap will be a dichotomous variable. We will use SatScan to identify clusters of children with treatment gaps using the Bernoulli model of purely spatial clusters. A ‘case’ will be a child with a treatment gap (child with epilepsy but without treatment), whereas a ‘control’ will be a child without such gap (child with epilepsy who at the time of ascertainment was receiving appropriate medical treatment). Appropriate medical treatment will be defined as treatment with an AED appropriate for the child's seizure type, regardless of whether the treatment has rendered the child seizure free at the time of the door-to-door survey. Separate locations of households are specified for each case and each control. We will vary the size and shape of the window that moves across Kano to identify these areas. The kml output file from the SatScan software will be overlaid with Google Earth to visually represent the clusters. The childhood epilepsy treatment gap within areas served by the PHCs, and the childhood epilepsy prevalence estimate using the door-to-door survey data will be determined. Four focus group discussions with patients and their family members will be conducted under the supervision of the Kano-based investigator to determine satisfaction with the epilepsy care team system. Similarly, four focus groups with CHOs, CHEWs, and of PHC leadership will be conducted near the end of the grant period to determine satisfaction with the epilepsy care team system. Each focus group will have about 8 participants. A consent form will be signed prior to the focus group sessions involving CHEWs, CHOs, and PHC Leadership. For qualitative data analysis, audio files will be transcribed, coded and analyzed using Atlas Ti© software. The data will be analyzed using mixed methods: Framework Analysis will be used to identify responses to our questions about the drivers, core facilitators, and barriers to the CHEWs successfully providing epilepsy care for children in the community with sub-analysis of each category done using Grounded Theory [78,79]. Two code maps will be developed to categorize data: (1) to understand the social, structural, and informational drivers, facilitators, barriers to CHEWs providing epilepsy care, and (2) to understand perceptions patients and family members have of CHEWs involvement in improving uptake of epilepsy care services. The data will be coded by our qualitative data analyst; analysis will be facilitated by NVivo [80,81]. We will track process outcomes related to Aim 1 activities, including the numbers of CHEWs who successfully complete the epilepsy education program and their performance in the program (as denoted by their scores on module quizzes). Outcomes for Specific Aim 2 will include CHEW and CHO adherence to the protocol, the level of accuracy and consistency in documentation of clinical activities by CHEWs and CHOs, and acceptance of the task-shifted epilepsy care by the physicians, CHEWs, CHOs, clinic administrators, and patient families. Aim 3 will be monitored with selected metrics, such as the number of completed meetings with key community leaders and stakeholders, in addition to quantitative data obtained from door-to-door surveys (e.g., number of children who screen positive for epilepsy, confirmed by epilepsy specialists and linked to care). All publications and reports as products of this research will be produced with leadership and/or involvement of all key personnel. Because the results of this research may have an impact on the Nigerian Federal Ministry of Health's plan for task-shifted care for mental health, and for the local healthcare officials in Kano, the final report of this study will be provided to local healthcare officials in Kano, as well as the Nigerian Federal Ministry of Health. The study PIs will meet with Nigerian Federal Ministry of Health officials, state and local government healthcare authorities in Kano, who have been engaged with the BRIDGE project from the beginning of the planning, to discuss the results of the research. The results of this research will be submitted for publication in the peer-reviewed literature. We anticipate several peer-reviewed publications on topics including, but not limited to the following: (a) an epilepsy education program for CHEWs and CHOs; (b) validation of a Hausa version of the childhood epilepsy and seizure type classification tool; (c) development of diagnostic paradigms supplementing the WHO guidelines for epilepsy diagnosis and management in LMICs of Africa; (d) mapping of the childhood epilepsy treatment gap in Kano; and, (e) developing task-shifted epilepsy care teams to reduce the childhood epilepsy treatment gap. The materials used in the training of the CHEWs and the data regarding the outcomes of the CHEW training will be published on a BRIDGE study website, and made available free to the public. In addition to the publication of articles in the peer-reviewed literature, PHCs and communities participating in this research will also receive presentations of the results of the research via community educational sessions in PHCs and other appropriate venues (e.g., radio). A final report submitted to NIH will also be provided to the AKTH Research Ethics Committee, the Kano State Ministry of Health, and the Vanderbilt University Medical Center IRB.